Homing of Functionally Distinct ILC Subsets
功能不同的 ILC 子集的归位
基本信息
- 批准号:9228316
- 负责人:
- 金额:$ 37.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-01 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensB-LymphocytesBacterial InfectionsBehaviorBiologyBone MarrowCCR6 geneCCR9 geneCXCR3 geneCell physiologyChronicDataDevelopmentEffector CellEpithelialHomingHoming BehaviorHost DefenseImmune responseImmunityImmunologyInfectionInflammationInflammatory ResponseInterferonsIntestinesKnowledgeLungLymphocyteLymphocyte SubsetLymphoid CellLymphoid TissueMarrowMediatingMucous MembraneNatural ImmunityOrganOutcomePhenotypePlayPopulationPositioning AttributeRecruitment ActivityRegulationResearchRoleSecondary toSiteT-LymphocyteTestingThromboplastinTimeTissuesWorkcell motilitycytokinefightinghematopoietic tissueimmune functioninsightinterestmigrationnovelnovel strategiespathogenpopulation migrationprogenitorprogramspublic health relevancereceptorreceptor expressiontissue repairtissue tropismtraffickingward
项目摘要
DESCRIPTION (provided by applicant): Optimal immune responses to pathogens in barrier tissues require timely regulation of lymphocyte recruitment to lymphoid tissues and effector sites. Innate lymphoid cells (ILCs) are cells of the lymphoid lineage and are enriched in mucosal tissues. They play important roles in fighting pathogens, inducing lymphoid tissue development and strengthening epithelial barrier function. ILCs are sub-divided into three major subsets with distinct effector cytokine phenotype: ILC1 produce the Th1 cytokine IFN-, ILC2 produce Th2 cytokines, and ILC3 produce Th17 cytokines. A major problem in the field is our lack of understanding of the migration program of ILC subsets. While ILCs are enriched in barrier tissues and distributed in a tissue-specific manner, we currently don't understand how ILCs migrate to these tissues for development and effector function. Our preliminary data raised the possibility that ILCs have highly sophisticated migration programs that support their development and effector function. Particularly, the data suggest that certain homing receptors regulate tissue-specific population, migration, and function of ILC subsets. We hypothesize that ILC subsets undergo potentially distinct homing receptor switches to migrate from the generative sites to lymphoid tissues and then to effector sites. Moreover, these homing receptor switches are likely to be regulated at multiple stages of ILC development in the bone marrow and periphery by cytokines and tissue factors. To test the hypothesis and obtain detailed information regarding ILC migration, we devised the following three specific aims: Aim 1. Determine the shared and differential migration programs of ILC subsets. Aim 2. Determine the roles of HRs in ILC migration and tissue tropism. Aim 3. Determine the impact of HRs on effector functions of ILC subsets. The project will generate fundamental knowledge on ILC migration and distribution in the body with a special emphasis on ILC subset-specific trafficking. Homing receptors important for ILC effector function and the factors that regulate the expression of these receptors will be identified. The outcomes will provide novel insights into the establishment of ILC immunity in barrier tissues.
描述(由申请人提供):对屏障组织中病原体的最佳免疫反应需要及时调节淋巴细胞向淋巴组织和效应位点的募集。先天淋巴样细胞(ILC)是淋巴谱系的细胞,富含于粘膜组织中。它们在对抗病原体、诱导淋巴组织发育和加强上皮屏障功能方面发挥着重要作用。 ILC 被细分为具有不同效应细胞因子表型的三个主要子集:ILC1 产生 Th1 细胞因子 IFN-γ,ILC2 产生 Th2 细胞因子,ILC3 产生 Th17 细胞因子。该领域的一个主要问题是我们对 ILC 子集的迁移程序缺乏了解。虽然 ILC 在屏障组织中富集并以组织特异性方式分布,但我们目前不了解 ILC 如何迁移到这些组织中以实现发育和效应功能。我们的初步数据表明,ILC 可能拥有高度复杂的迁移程序来支持其发育和效应器功能。特别是,数据表明某些归巢受体调节 ILC 亚群的组织特异性群体、迁移和功能。我们假设 ILC 子集经历潜在不同的归巢受体转换,从生成位点迁移到淋巴组织,然后迁移到效应位点。此外,这些归巢受体开关可能在骨髓和外周 ILC 发育的多个阶段受到细胞因子和组织因子的调节。为了检验假设并获得有关 ILC 迁移的详细信息,我们设计了以下三个具体目标: 目标 1. 确定 ILC 子集的共享和差异迁移程序。目标 2. 确定 HR 在 ILC 迁移和组织向性中的作用。目标 3. 确定 HR 对 ILC 子集效应器功能的影响。该项目将产生有关 ILC 在体内迁移和分布的基础知识,特别强调 ILC 子集特定的贩运。将鉴定对 ILC 效应器功能重要的归巢受体以及调节这些受体表达的因素。研究结果将为屏障组织中 ILC 免疫的建立提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHANG H KIM其他文献
CHANG H KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHANG H KIM', 18)}}的其他基金
Mobilization and trafficking of central ILC progenitors
中央 ILC 祖细胞的动员和贩运
- 批准号:
10766537 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Mobilization and trafficking of central ILC progenitors
中央 ILC 祖细胞的动员和贩运
- 批准号:
10732869 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Regulation of the development of dendritic cells in barrier tissues by retinoid gradients
通过类维生素A梯度调节屏障组织中树突状细胞的发育
- 批准号:
10092940 - 财政年份:2020
- 资助金额:
$ 37.9万 - 项目类别:
A multiphoton confocal microscope for biomedical research at Purdue University
普渡大学用于生物医学研究的多光子共焦显微镜
- 批准号:
7813549 - 财政年份:2010
- 资助金额:
$ 37.9万 - 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
- 批准号:
8501249 - 财政年份:2010
- 资助金额:
$ 37.9万 - 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
- 批准号:
8115882 - 财政年份:2010
- 资助金额:
$ 37.9万 - 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
- 批准号:
7882855 - 财政年份:2010
- 资助金额:
$ 37.9万 - 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
- 批准号:
8306171 - 财政年份:2010
- 资助金额:
$ 37.9万 - 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
- 批准号:
7930000 - 财政年份:2009
- 资助金额:
$ 37.9万 - 项目类别:
Therapeutic delivery of FoxP3+ T cells to the intestine
将 FoxP3 T 细胞治疗性递送至肠道
- 批准号:
8230608 - 财政年份:2008
- 资助金额:
$ 37.9万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 37.9万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:














{{item.name}}会员




